rHDL

DRUG2 trials

Sponsors

CSL Limited, Bayside Health

Conditions

Acute Coronary SyndromesDiabetesHeart Disease

Phase 2

Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL

CompletedNCT00225719

CSL LimitedAcute Coronary Syndromes

Start: 2005-07-31Target: 180Updated: 2008-11-10

Unknown Phase

Improving Metabolism With HDL Cholesterol

CompletedNCT00395148

Bayside HealthDiabetes, Heart Disease

Start: 2006-03-31End: 2008-03-31Updated: 2011-05-10

Related Papers

Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.

2009-11-09142 citations

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

2007-03-26539 citations